Search
Returning search results with filters:
Remove filter for
Issue: COVID
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 23 items.
… Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels Starting … On December 23, 2020, Moderna COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02510014) was authorized in accordance …
AlertHealth professional risk communication | 2020-12-23
… SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) COVID-19 Vaccine with English-only Vial and Carton Labels … 3, 2022 . In order to provide rapid access to the vaccine, Moderna will distribute product vials and cartons labelled in …
AlertHealth professional risk communication | 2022-11-18
… Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels … . In order to provide rapid access to SPIKEVAX Bivalent , Moderna will distribute product vials and cartons labelled in …
AlertHealth professional risk communication | 2022-09-02
… Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with … of SPIKEVAX (0.1 0 mg/mL, 2.5 mL multidose vial), Moderna will distribute vaccine product with English-only …
AlertHealth professional risk communication | 2022-06-06
… Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels … during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) Audience …
AlertHealth professional risk communication | 2021-03-31
… Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels Starting … 9, 2020, Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02509210) was authorized in accordance …
AlertHealth professional risk communication | 2020-12-12
… Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels Starting … during the initial distribution of the AstraZeneca COVID-19 Vaccine. Audiences Healthcare professionals …
AlertHealth professional risk communication | 2021-03-01
… and distributor) is initially distributing COVISHIELD (COVID-19 Vaccine) doses directly to vaccination locations where … (manufactured by Serum Institute of India) and AstraZeneca COVID-19 VACCINE (manufactured by AstraZeneca) are ChAdOx1-S …
AlertHealth professional risk communication | 2021-03-01
… with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: December 18, 2020 Posting date: … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of …
AlertHealth professional risk communication | 2020-12-18
… seek medical help immediately. To help limit the spread of COVID-19, wash your hands often with soap and water for at least 20 … (DIN) but have been accepted for use in Canada during the COVID-19 pandemic. Report any health product adverse events …
AlertPublic advisory | 2022-09-12
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome … have been reported following vaccination with AstraZeneca COVID-19 Vaccine. A history of CLS was noted in some of the …
AlertHealth professional risk communication | 2021-06-29
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with … very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the available data on …
AlertHealth professional risk communication | 2021-03-24
… Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels Starting … information during the initial distribution of the Janssen COVID-19 Vaccine. Audience Healthcare professionals including …
AlertHealth professional risk communication | 2021-03-08
… Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market … the PM for Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) to reflect this new information. Health Canada …
AlertHealth professional risk communication | 2021-02-09
… of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic Starting date: September 22, 2021 Posting date: … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Sotrovimab is indicated for the treatment of mild …
AlertHealth professional risk communication | 2021-10-04